Html code here! Replace this with any non empty raw html code and that's it.

GLP-1 drugs linked to reduced need for migraine treatment

Date:

Share this article:

Del denne artikel:

New research points to a link between GLP-1 medication and chronic migraine.

According to a press release from the American Academy of Neurology, patients with chronic migraine who began GLP-1 drugs for conditions such as diabetes or weight loss were less likely to require new preventive migraine medication.

They were compared with patients who started topiramate, which is often used to treat migraine.

In the group taking GLP-1 medication, prescriptions for drugs such as valproate, calcitonin gene-related peptide (CGRP) monoclonal antibodies, tricyclic antidepressants, and gepants were issued less frequently. There was no difference in the use of beta blockers.

The researchers note that the difference was consistent across several types of preventive treatment.

Also read: Girls aged 13 to 15 in Europe have the highest tobacco use in the world

Fewer hospital visits

The study is based on health data from approximately 22,000 people with chronic migraine.

The condition is defined as having headaches on at least 15 days per month for three months, with at least eight days involving typical migraine symptoms.

Participants were followed for one year after starting treatment.

Among those receiving GLP-1 medication, 23.7 percent visited the emergency department during the period. In the topiramate group, the figure was 26.4 percent.

Also read: Can daily peanut butter improve strength in older adults? New study provides answers

In addition, the GLP-1 group had fewer hospital admissions, fewer nerve blocks, and fewer prescriptions for triptans, which are used to treat acute migraine attacks.

Requires further research

The study is observational, meaning it cannot establish whether the medication directly caused the differences.

Other factors, such as weight loss or changes in disease severity, may have played a role.

The results are scheduled to be presented at the American Academy of Neurology’s annual meeting in April 2026. However, the researchers emphasize that further studies are needed.

Also read: These bodily symptoms may be linked to high blood pressure

Sources: News Medical, and American Academy of Neurology.

Also read: How to deal with stubborn white spots on the skin

Other articles

Study of 1.2 million children finds vegan infants grow at normal rates

A large study has examined how infants grow on vegan, vegetarian, or omnivorous diets.

Girls aged 13 to 15 in Europe have the highest tobacco use in the world

A new report from the World Health Organization indicates that Europe has the highest proportion of smokers globally. The situation is particularly concerning among girls.

Can daily peanut butter improve strength in older adults? New study provides answers

A new study has examined whether peanut butter can strengthen the bodies of older adults. The results show a small improvement in one area.

These bodily symptoms may be linked to high blood pressure

High blood pressure usually causes no noticeable symptoms, but in severe cases the body can send serious warning...

Study of 1.2 million children finds vegan infants grow at normal rates

A large study has examined how infants grow on vegan, vegetarian, or omnivorous diets.

Girls aged 13 to 15 in Europe have the highest tobacco use in the world

A new report from the World Health Organization indicates that Europe has the highest proportion of smokers globally. The situation is particularly concerning among girls.

Can daily peanut butter improve strength in older adults? New study provides answers

A new study has examined whether peanut butter can strengthen the bodies of older adults. The results show a small improvement in one area.